The trajectory of Viagra presents a complex picture for shareholders. While the initial release generated substantial returns, the end of its exclusive rights opened the floodgates to off-brand versions, dramatically https://indexedbookmarks.com/story21548157/sildenafil-and-pharma-a-volatile-bet